Search research articles
Contact Us
Filters
Showing results (141-150 of 316) with videos related to
Page
of 32
Sort By:
British Journal of Cancer
|
May 1, 1993
In vitro testing of chemotherapeutic drug combinations in acute myelocytic leukaemia using the fluorometric microculture cytotoxicity assay (FMCA)
R Larsson, H Fridborg, J Kristensen, et al.
Anticancer Research
|
January 1, 1989
Early ionic events associated with phorbol ester induced differentiation and inhibition of cell growth in hematopoietic tumor cell lines
R Larsson, P Nygren, K Forsbeck, et al.
British Journal of Cancer
|
August 14, 1998
Comparison of the cytotoxic activity of melphalan with L-prolyl-m-L-sarcolysyl-L-p-fluorophenylalanine in human tumour cell lines and primary cultures of tumour cells from patients
R Larsson, S Dhar, H Ehrsson, et al.
Journal of Chemical Theory and Computation
|
January 21, 2022
Matrix Product States with Large Sites
Henrik R Larsson, Huanchen Zhai, Klaas Gunst, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1985
Prostaglandin synthase catalyzed metabolic activation of p-phenetidine and acetaminophen by microsomes isolated from rabbit and human kidney
R Larsson, D Ross, T Berlin, et al.
Biomaterials
|
April 20, 1999
A new in vitro model to study interaction between whole blood and biomaterials. Studies of platelet and coagulation activation and the effect of aspirin
J Hong, K Nilsson Ekdahl, H Reynolds, et al.
The Journal of Chemical Physics
|
June 6, 2018
Resonance dynamics of DCO (X̃<sup> 2</sup>A<sup>'</sup>) simulated with the dynamically pruned discrete variable representation (DP-DVR)
Henrik R Larsson, Jens Riedel, Jie Wei, et al.
Leukemia
|
May 10, 2000
Cellular cytotoxic drug sensitivity in children with acute leukemia and Down's syndrome: an explanation to differences in clinical outcome?
B M Frost, G Gustafsson, R Larsson, et al.
Biosensors & Bioelectronics
|
November 18, 2005
A novel application of multi-wavelength TIRF spectroscopy for real time monitoring of antithrombin interactions with immobilized heparin
J E Klinth, R Larsson, P O Andersson, et al.
Anti-Cancer Drugs
|
August 21, 2002
In vitro activity of the novel cytotoxic agent CHS 828 in childhood acute leukemia
B-M Frost, G Lönnerholm, P Nygren, et al.
Page
of 32
Search research articles
Search
Showing results (141-150 of 316) with videos related to
Sort By:
Page
of 32
British Journal of Cancer
|
May 1, 1993
In vitro testing of chemotherapeutic drug combinations in acute myelocytic leukaemia using the fluorometric microculture cytotoxicity assay (FMCA)
R Larsson, H Fridborg, J Kristensen, et al.
Anticancer Research
|
January 1, 1989
Early ionic events associated with phorbol ester induced differentiation and inhibition of cell growth in hematopoietic tumor cell lines
R Larsson, P Nygren, K Forsbeck, et al.
British Journal of Cancer
|
August 14, 1998
Comparison of the cytotoxic activity of melphalan with L-prolyl-m-L-sarcolysyl-L-p-fluorophenylalanine in human tumour cell lines and primary cultures of tumour cells from patients
R Larsson, S Dhar, H Ehrsson, et al.
Journal of Chemical Theory and Computation
|
January 21, 2022
Matrix Product States with Large Sites
Henrik R Larsson, Huanchen Zhai, Klaas Gunst, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1985
Prostaglandin synthase catalyzed metabolic activation of p-phenetidine and acetaminophen by microsomes isolated from rabbit and human kidney
R Larsson, D Ross, T Berlin, et al.
Biomaterials
|
April 20, 1999
A new in vitro model to study interaction between whole blood and biomaterials. Studies of platelet and coagulation activation and the effect of aspirin
J Hong, K Nilsson Ekdahl, H Reynolds, et al.
The Journal of Chemical Physics
|
June 6, 2018
Resonance dynamics of DCO (X̃<sup> 2</sup>A<sup>'</sup>) simulated with the dynamically pruned discrete variable representation (DP-DVR)
Henrik R Larsson, Jens Riedel, Jie Wei, et al.
Leukemia
|
May 10, 2000
Cellular cytotoxic drug sensitivity in children with acute leukemia and Down's syndrome: an explanation to differences in clinical outcome?
B M Frost, G Gustafsson, R Larsson, et al.
Biosensors & Bioelectronics
|
November 18, 2005
A novel application of multi-wavelength TIRF spectroscopy for real time monitoring of antithrombin interactions with immobilized heparin
J E Klinth, R Larsson, P O Andersson, et al.
Anti-Cancer Drugs
|
August 21, 2002
In vitro activity of the novel cytotoxic agent CHS 828 in childhood acute leukemia
B-M Frost, G Lönnerholm, P Nygren, et al.
Page
of 32